Publications Repository

Publications Repository

View item 
  •   Home
  • ICR Divisions
  • Clinical Studies
  • View item
  • Home
  • ICR Divisions
  • Clinical Studies
  • View item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Systemic therapy in retroperitoneal sarcoma management.

Thumbnail
View/Open
Supporting information (63.31Kb)
Date
2018-01
ICR Author
Jones, Robin
Marsden,
Author
Constantinidou, A
Jones, RL
Type
Journal Article
Metadata
Show full item record
Abstract
There is paucity of randomized controlled data on the role of systemic therapy in retroperitoneal sarcomas. The type of systemic therapy used is guided by the histological subtype. The majority of retroperitoneal sarcomas comprising liposarcomas and leiomyosarcomas are by and large chemotherapy insensitive. There is an urgent need for more efficacious systemic therapies in the management of early and advanced stage retroperitoneal sarcomas.
URI
https://repository.icr.ac.uk/handle/internal/1081
DOI
https://doi.org/10.1002/jso.24933
Collections
  • Clinical Studies
Subject
Humans
Sarcoma
Retroperitoneal Neoplasms
Combined Modality Therapy
Disease Management
Research team
Sarcoma Clinical Trials (R Jones)
Language
eng
Date accepted
2017-11-02
License start date
2018-01
Citation
Journal of surgical oncology, 2018, 117 (1), pp. 87 - 92

Browse

All of ICR repositoryICR DivisionsBy issue dateAuthorsTitlesPublication TypesThis collectionBy issue dateAuthorsTitlesPublication Types
  • Login
  • Registered office: The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP
    A Charity, Not for Profit. Company Limited by Guarantee.
    Registered in England No. 534147. VAT Registration No. GB 849 0581 02.